138 related articles for article (PubMed ID: 18587272)
1. Development of thymic lymphomas in mice disrupted of Brca2 allele in the thymus.
Park PG; Lee H
Exp Mol Med; 2008 Jun; 40(3):339-44. PubMed ID: 18587272
[TBL] [Abstract][Full Text] [Related]
2. Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.
Lee H
Exp Mol Med; 2003 Oct; 35(5):448-53. PubMed ID: 14646599
[TBL] [Abstract][Full Text] [Related]
3. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma.
Yin B; Yang-Iott KS; Chao LH; Bassing CH
Blood; 2011 Jan; 117(1):175-85. PubMed ID: 20947684
[TBL] [Abstract][Full Text] [Related]
4. Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis.
Cheung AM; Hande MP; Jalali F; Tsao MS; Skinnider B; Hirao A; McPherson JP; Karaskova J; Suzuki A; Wakeham A; You-Ten A; Elia A; Squire J; Bristow R; Hakem R; Mak TW
Cancer Res; 2002 Nov; 62(21):6194-204. PubMed ID: 12414647
[TBL] [Abstract][Full Text] [Related]
5. Brca2 deficiency leads to T cell loss and immune dysfunction.
Jeong JH; Jo A; Park P; Lee H; Lee HO
Mol Cells; 2015 Mar; 38(3):251-8. PubMed ID: 25666348
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
[TBL] [Abstract][Full Text] [Related]
7. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW
Blood; 2008 Feb; 111(4):2163-9. PubMed ID: 17855626
[TBL] [Abstract][Full Text] [Related]
8. Suppression of thymic lymphomas and increased nonthymic lymphomagenesis in Trp53-deficient mice lacking inducible nitric oxide synthase gene.
Tatemichi M; Tazawa H; Masuda M; Saleem M; Wada S; Donehower LA; Ohgaki H; Ohshima H
Int J Cancer; 2004 Oct; 111(6):819-28. PubMed ID: 15300793
[TBL] [Abstract][Full Text] [Related]
9. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
Haines BB; Ryu CJ; Chang S; Protopopov A; Luch A; Kang YH; Draganov DD; Fragoso MF; Paik SG; Hong HJ; DePinho RA; Chen J
Cancer Cell; 2006 Feb; 9(2):109-20. PubMed ID: 16473278
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
11. Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse.
Boulton E; Cleary H; Plumb M
Carcinogenesis; 2002 Jun; 23(6):1079-85. PubMed ID: 12082032
[TBL] [Abstract][Full Text] [Related]
12. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.
Morales JC; Franco S; Murphy MM; Bassing CH; Mills KD; Adams MM; Walsh NC; Manis JP; Rassidakis GZ; Alt FW; Carpenter PB
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3310-5. PubMed ID: 16492765
[TBL] [Abstract][Full Text] [Related]
13. Direct detection of p53 -/- thymocyte appearing at an early stage of radiation-induced thymic lymphomagenesis in p53 +/- heterozygous B10 mice.
Aizawa S; Tanaka K; Mori M; Tsuji S; Yoshida K
Int J Radiat Biol; 2007 Apr; 83(4):259-67. PubMed ID: 17575953
[TBL] [Abstract][Full Text] [Related]
14. The evolution of thymic lymphomas in p53 knockout mice.
Dudgeon C; Chan C; Kang W; Sun Y; Emerson R; Robins H; Levine AJ
Genes Dev; 2014 Dec; 28(23):2613-20. PubMed ID: 25452272
[TBL] [Abstract][Full Text] [Related]
15. Loss of Setd4 delays radiation-induced thymic lymphoma in mice.
Feng X; Lu H; Yue J; Schneider N; Liu J; Denzin LK; Chan CS; De S; Shen Z
DNA Repair (Amst); 2020 Feb; 86():102754. PubMed ID: 31794893
[TBL] [Abstract][Full Text] [Related]
16. Thymic lymphomas in mice with a truncating mutation in Brca2.
Friedman LS; Thistlethwaite FC; Patel KJ; Yu VP; Lee H; Venkitaraman AR; Abel KJ; Carlton MB; Hunter SM; Colledge WH; Evans MJ; Ponder BA
Cancer Res; 1998 Apr; 58(7):1338-43. PubMed ID: 9537225
[TBL] [Abstract][Full Text] [Related]
17. Comparison of properties of spontaneous and radiation-induced mouse thymic lymphomas: role of Trp53 and radiation.
Kubota T; Yoshikai Y; Tamura Y; Mishima Y; Aoyagi Y; Niwa O; Kominami R
Radiat Res; 2005 Feb; 163(2):159-64. PubMed ID: 15658891
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenicity of 2',3'-dideoxycytidine in mice.
Rao GN; Collins BJ; Giles HD; Heath JE; Foley JF; May RD; Buckley LA
Cancer Res; 1996 Oct; 56(20):4666-72. PubMed ID: 8840982
[TBL] [Abstract][Full Text] [Related]
19. Effect of Bcl11b genotypes and gamma-radiation on the development of mouse thymic lymphomas.
Yoshikai Y; Sato T; Morita S; Kohara Y; Takagi R; Mishima Y; Kominami R
Biochem Biophys Res Commun; 2008 Aug; 373(2):282-5. PubMed ID: 18558082
[TBL] [Abstract][Full Text] [Related]
20. Development of prelymphoma cells committed to thymic lymphomas during radiation-induced thymic lymphomagenesis in B10 mice.
Muto M; Kubo E; Sado T
Cancer Res; 1987 Jul; 47(13):3469-72. PubMed ID: 3495331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
